Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition
Autor: | Angela Leo, Valentina Gori, L. Piccini, Maria Letizia Taddei, Matteo Lulli, Laura Pietrovito, Franco Bambi, Matteo Parri, Valentina Becherucci, Paola Chiarugi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
transendothelial migration Cancer Research RHOA Carcinogenesis Neovascularization Physiologic Motility Bone Marrow Cells lcsh:RC254-282 03 medical and health sciences 0302 clinical medicine Cancer-Associated Fibroblasts Cell Line Tumor osteosarcoma Human Umbilical Vein Endothelial Cells Genetics medicine Humans Neoplasm Invasiveness Neoplasm Metastasis Bone marrow-derived mesenchymal stem cells cytokines tumor plasticity Research Articles tumour plasticity biology Chemistry Mesenchymal stem cell Transendothelial and Transepithelial Migration Interleukin Mesenchymal Stem Cells Chemotaxis General Medicine medicine.disease lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Phenotype 030104 developmental biology medicine.anatomical_structure Oncology Culture Media Conditioned 030220 oncology & carcinogenesis biology.protein Cancer research Intercellular Signaling Peptides and Proteins Molecular Medicine Osteosarcoma bone marrow‐derived mesenchymal stem cells Bone marrow Research Article Transforming growth factor |
Zdroj: | Molecular Oncology, Vol 12, Iss 5, Pp 659-676 (2018) Molecular Oncology |
ISSN: | 1574-7891 1878-0261 |
Popis: | There is growing evidence to suggest that bone marrow-derived mesenchymal stem cells (BM-MSCs) are key players in tumour stroma. Here, we investigated the cross-talk between BM-MSCs and osteosarcoma (OS) cells. We revealed a strong tropism of BM-MSCs towards these tumour cells and identified monocyte chemoattractant protein (MCP)-1, growth-regulated oncogene (GRO)-α and transforming growth factor (TGF)-β1 as pivotal factors for BM-MSC chemotaxis. Once in contact with OS cells, BM-MSCs trans-differentiate into cancer-associated fibroblasts, further increasing MCP-1, GRO-α, interleukin (IL)-6 and IL-8 levels in the tumour microenvironment. These cytokines promote mesenchymal to amoeboid transition (MAT), driven by activation of the small GTPase RhoA, in OS cells, as illustrated by the in vitro assay and live imaging. The outcome is a significant increase of aggressiveness in OS cells in terms of motility, invasiveness and transendothelial migration. In keeping with their enhanced transendothelial migration abilities, OS cells stimulated by BM-MSCs also sustain migration, invasion and formation of the in vitro capillary network of endothelial cells. Thus, BM-MSC recruitment to the OS site and the consequent cytokine-induced MAT are crucial events in OS malignancy. |
Databáze: | OpenAIRE |
Externí odkaz: |